Absci JPM 2026 Presentation.pdf

1、2026 J.P.MORGAN HEALTHCARE CONFERENCEGENERATIVE AIDRUGCREATIONDisclaimersF O R W A R D-L O O K I N G S T A T E M E N T S Statements contained in this press release regarding matters that are not historical facts are“forward-looking statements”within the meaning of the Private Securities Litigation R

2、eform Act of 1995.Because such statements are subject to risks and uncertainties,actual results may differ materially from those expressed or implied by such forward-looking statements.Such statements include,but are not limited to,statements regarding any or all of the following:(i)Abscis preclinic

3、al studies,clinical trials,as well as partnered and internally developed programs,including,without limitation,manufacturing capabilities,status of such studies and trials and expectations regarding data,safety and efficacy generally;(ii)data included in the above-described oral presentation,as well

4、 as the ability to use data from ongoing and planned clinical trials for the design and initiation of further clinical trials;(iii)Abscis strategy,goals,anticipated financial performance and the sufficiency of its cash resources;(iv)regulatory submissions and authorizations,including timelines for a

5、nd expectations regarding any anticipated regulatory agency decisions;(v)the expected benefits of its collaborations with partners;and(vi)the therapeutic value,development,and commercial potential of antibody therapies,as well as other technologies.Risks that contribute to the uncertain nature of th

6、e forward-looking statements include,without limitation,the risks and uncertainties discussed under the heading“Risk Factors”inAbsci Corporations most recent annual report on Form 10-K and in any other subsequent filings made by Absci Corporation with the U.S.Securities and Exchange Commission.Exist